EPAS1 and adenocarcinoma: In addition, data analysis from the International Cancer Genome Consortium (ICGC) revealed that mutations in EPAS1 are common in many human malignancies, including esophageal cancer (adenocarcinoma) (https://dcc.icgc.org/).